Showing results (1-10 of 271) with videos related to
Sort By:
Pageof 28
Blood|October 22, 2021
Therapeutic options for relapsed/refractory mantle cell lymphomaToby A Eyre, Chan Y Cheah, Michael L WangJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2022
Emerging Therapies for the Management of Richter TransformationElizabeth Smyth, Toby A Eyre, Chan Y CheahJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2025
Mantle Cell Lymphoma: Optimal Treatment With Bruton Tyrosine Kinase-Targeted ApproachesToby A Eyre, Chan Y Cheah, Clémentine Sarkozy, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 13, 2022
New Directions for Mantle Cell Lymphoma in 2022Anita Kumar, Toby A Eyre, Katharine L Lewis, et al.British Journal of Haematology|June 14, 2026
Where next for BTKi-BCL2i combinations in mantle cell lymphoma?Toby A EyreHematology. American Society of Hematology. Education Program|December 9, 2023
Richter transformation-is there light at the end of this tunnel?Toby A EyreOncotarget|March 23, 2019
Correction: Predictive biomarkers for disease sensitivity in lymphoma - the holy grail for HDAC inhibitors?Toby A EyreBritish Journal of Haematology|April 26, 2017
An update for Richter syndrome - new directions and developmentsToby A Eyre, Anna SchuhBritish Journal of Haematology|April 1, 2015
Immune checkpoint inhibition in lymphoid diseaseToby A Eyre, Graham P CollinsCancers|May 13, 2023
The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future PerspectivesToby A Eyre, John C RichesPageof 28